Workshop Part 3 Registration

Name

This address will receive a confirmation email

Phone

Address

Birthdate

Age Group

18 - 35 36 - 55 56 and Older

Gender

Male Female Non-Binary

Race/Ethnicity

African American or African or Black or Caribbean American Indian or Alaskan Native Asian or Pacific Islander Caucasian or white Hispanic or Latino Multi-Racial or Bi-racial

How would you describe your smoking history?

I currently smoke (cigarettes, cigars, hookah, or cannabis) I smoked in the past, but I am not smoking now I have never smoked

What is your current level of knowledge about comprehensive biomarker testing in lung cancer?

No knowledge Low Moderate High Expert

Have you or a family member received comprehensive biomarker testing?

Yes No

If your doctor recommended comprehensive biomarker testing in the treatment of lung cancer, how likely are you to consider completing biomarker testing?

Very Likely Likely Unsure Unlikely Very Unlikely

How did you hear about the program?

Impact Church Grady Medical Systems HEAL Collaborative Morehouse School of Medicine AMGEN Other

Please specify what barriers or difficulties have you faced in trying to learn about biomarker testing and precision medicine.

Please use this space to ask any questions aabout biomarker testing and precision medicine.

What do you hope to learn from this program?

WORKSHOP PART 23 OVERVIEW

WHEN | WHERE:
Saturday, August 6, 2022 | 11:00 am - 12:30 pm

EVENT DETAILS:
Participants will learn about how physicians utilize biomarker testing to optimize treatment decisions that are improving lung cancer survival through precision medicine. Precision medicine is a model that allows physicians to personalize treatment decisions for each person diagnosed with lung cancer. The personalized approach involves your primary care physician, surgeon, and oncologist working together to identify the best treatment that will more effectively target your specific type of lung cancer. Healthcare professionals will discuss how to improve access to biomarker testing and precision medicine in communities of color.

LEARNING OBJECTIVES:
1. To define the role of biomarker testing in transforming lung cancer to a treatable disease
2. To translate how advances in immunotherapy, targeted therapies, and lung cancer treatment are improving lung cancer survival and quality of life
3. To discuss why health equities, exist in cancer treatment
4. To evaluate how policy leaders can improve access and equity to comprehensive biomarker testing
5. To demonstrate how to obtain resources and support from non-profits and survivor advocacy groups

BREATH OF LIFE WORKSHOP SERIES

WHAT CAN YOU PLAN TO GAIN FROM OUR BREATH OF LIFE WORKSHOP SERIES?

*Education on lung cancer physiology, incidence, racial/health disparities, and risk factors.
*Strategies & Interventions on risk reduction and prevention.

Anyone with lungs can get lung cancer!

It's more than a "smoking disease!"

WORKSHOP SERIES DETAILS

WHAT TO EXPECT: A series of workshops that will cover lung cancer incidence, health disparities, risk factors, early detection, life saving treatments and therapies, biomarker testing, clinical trials and more.The hope of a healthy future is possible. We hope that you will join us in our efforts to connect and share information with communities of color. Together, we can fight this!

WHEN: 1st Saturdays, June - September 2022
Saturday, June 4, 2022
Saturday, July 2, 2022
Saturday, August 6, 2022
Saturday, September 3, 2022

WHAT TIME: 11:00 am until 12:30 pm

WHERE: Virtual

Workshop Part 3 Registration

Description

Please Fix the Following